BridgeBio Pharma, Inc. · NASDAQ:BBIO

Kumar Neil sold 54,980 BridgeBio Pharma, Inc. shares (Form 4)

Traded Nov 18 to Nov 19, 2026 · Filed Nov 20, 2026

From Nov 18 to Nov 19, 2026, Kumar Neil (Director, Chief Executive Officer) sold 54,980 BridgeBio Pharma, Inc. shares at an average US$77.86 for US$4.28M under a trading plan, leaving 475,686 shares. Filed Nov 20, 2026 (Form 4).

Sold
54,980 shares
Price
US$77.86 average (US$76.99 to US$79.29)
Value
US$4.28M
Holding after
475,686 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 18, 2026Common StockSale4,490US$76.99273,817Direct
Nov 18, 2026Common StockSale30,490US$77.83243,327Direct
Nov 18, 2026Common StockSale1,277US$76.99494,409Indirect
Nov 18, 2026Common StockSale8,723US$77.83485,686Indirect
Nov 19, 2026Common StockSale8,500US$78.35477,186Indirect
Nov 19, 2026Common StockSale1,500US$79.29475,686Indirect

Source

Download original · View original at SEC

Related